(VIANEWS) – Shares of NORDIC NANOVECTOR (Oslo Børs All-share Index_GI: NANOV.OL) fell by a staggering 15.94% in 5 sessions from 1.03 kr to 0.87 kr at 22:41 EST on Wednesday, following the last session’s downward trend. Oslo Børs All-share Index_GI is jumping 2.81% to 1,415.94 kr, following the last session’s downward trend.
NORDIC NANOVECTOR’s last close was 0.88 kr, 94.4% under its 52-week high of 15.78 kr.
About NORDIC NANOVECTOR
Nordic Nanovector ASA, a biopharmaceutical company, develops and commercializes therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting antibody-radionuclide-conjugate, which is in Phase 2b clinical trial for the treatment of patients with non-hodgkin lymphoma. Its preclinical development product also includes Alpha37, an anti-CD37 alphaparticle emitting radioimmunoconjugate for treating chronic lymphatic leukemia. The company has collaboration agreements with Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania to generate a CD37-targeting CAR-T cell approach as a treatment for patients with B-cell malignancies. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of -4.377 kr.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -155.9%.
Volume
Today’s last reported volume for NORDIC NANOVECTOR is 456368 which is 80.19% below its average volume of 2304370.
Yearly Top and Bottom Value
NORDIC NANOVECTOR’s stock is valued at 0.87 kr at 22:41 EST, under its 52-week low of 0.90 kr.
Volatility
NORDIC NANOVECTOR’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.95%, a negative 0.91%, and a positive 4.29%.
NORDIC NANOVECTOR’s highest amplitude of average volatility was 3.31% (last week), 2.51% (last month), and 4.29% (last quarter).
Moving Average
NORDIC NANOVECTOR’s worth is way under its 50-day moving average of 1.04 kr and way under its 200-day moving average of 3.26 kr.
More news about NORDIC NANOVECTOR (NANOV.OL).